Skip to Main Content
WELCOME TO CREX, THE COLLABORATIVE RESEARCH EXCHANGE FOR THE NIH INTRAMURAL RESEARCH PROGRAM

Go to Main Navigation
May 30, 2013

Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...

May 28, 2013

We’ve covered the importance of tactical vs strategic outsourcing and the potential for savings and innovation by outsourcing, and now we’ll be...

May 23, 2013

Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke. As a common underlying factor in so many preventable...

May 21, 2013

In the past 10 years, we’ve experienced a shift: the move from in-person to virtual interactions. Email, Facebook, Twitter, and a slew of other...

May 9, 2013

Innovative research is being performed in universities worldwide. There is a quest for knowledge, glory, and most importantly, helping the sick. On...

Apr 30, 2013

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Apr 24, 2013

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

Apr 23, 2013

This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Apr 18, 2013

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

Apr 16, 2013

In two compelling presentations at the Bio-IT World Conference last week, Atul Butte and Steven Salzberg provided formidable advocacy for the...